BRIDGEBIO PHARMA INC's ticker is BBIO and the CUSIP is 10806X102. A total of 208 filers reported holding BRIDGEBIO PHARMA INC in Q2 2021. The put-call ratio across all filers is 1.95 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $507,000 | +38.1% | 19,259 | -9.6% | 0.00% | – |
| Q2 2023 | $367,000 | -18.8% | 21,301 | -21.8% | 0.00% | – |
| Q1 2023 | $452,000 | +195.4% | 27,254 | +34.6% | 0.00% | – |
| Q4 2022 | $153,000 | +8.5% | 20,244 | +43.1% | 0.00% | – |
| Q3 2022 | $141,000 | -25.4% | 14,146 | -32.0% | 0.00% | – |
| Q2 2022 | $189,000 | -10.0% | 20,806 | +0.5% | 0.00% | – |
| Q1 2022 | $210,000 | -62.0% | 20,706 | -37.6% | 0.00% | – |
| Q4 2021 | $553,000 | +36.5% | 33,168 | +283.7% | 0.00% | – |
| Q3 2021 | $405,000 | -27.3% | 8,645 | -5.4% | 0.00% | – |
| Q2 2021 | $557,000 | -2.3% | 9,141 | -1.3% | 0.00% | – |
| Q1 2021 | $570,000 | +540.4% | 9,258 | +635.3% | 0.00% | – |
| Q4 2020 | $89,000 | +4350.0% | 1,259 | +1724.6% | 0.00% | – |
| Q2 2020 | $2,000 | -80.0% | 69 | -80.3% | 0.00% | – |
| Q1 2020 | $10,000 | -76.7% | 351 | -71.6% | 0.00% | – |
| Q4 2019 | $43,000 | +1333.3% | 1,238 | +703.9% | 0.00% | – |
| Q3 2019 | $3,000 | – | 154 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aisling Capital Management LP | 6,068,125 | $160,016,456 | 65.94% |
| Kohlberg Kravis Roberts & Co. L.P. | 31,060,971 | $819,077,805 | 28.79% |
| Cormorant Asset Management, LP | 4,662,530 | $122,950,916 | 7.17% |
| Frazier Life Sciences Management, L.P. | 2,725,949 | $71,883,275 | 4.77% |
| Octagon Capital Advisors LP | 971,639 | $25,622,120 | 3.94% |
| M28 Capital Management LP | 121,200 | $3,196,044 | 3.66% |
| VIKING GLOBAL INVESTORS LP | 25,120,991 | $662,440,533 | 2.69% |
| BOONE CAPITAL MANAGEMENT LLC | 313,381 | $8,263,857 | 2.61% |
| Fernwood Investment Management, LLC | 235,620 | $6,213,299 | 2.23% |
| SOUTHPORT MANAGEMENT, L.L.C. | 15,000 | $395,550 | 2.15% |